Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

CRx-102 Osteoarthritis Multicenter Evaluation Trial

ClinicalTrials.gov ID: NCT00521989

Public ClinicalTrials.gov record NCT00521989. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy of CRx-102 in Subjects With Symptomatic Knee Osteoarthritis and Optional One-Year Extension

Study identification

NCT ID
NCT00521989
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Zalicus
Industry
Enrollment
279 participants

Conditions and interventions

Interventions

  • CRx-102 (2.7/90) Drug
  • Prednisolone Drug
  • Placebo Drug
  • CRx-102 (2.7/180) Drug
  • CRx-102 (2.7/360) Drug

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2007
Primary completion
Jun 30, 2009
Completion
Jun 30, 2009
Last update posted
Apr 28, 2014

2007 – 2009

United States locations

U.S. sites
57
U.S. states
27
U.S. cities
57
Facility City State ZIP Site status
Not listed Huntsville Alabama
Not listed Chandler Arizona
Not listed Mesa Arizona
Not listed Phoenix Arizona
Not listed Tuscon Arizona
Not listed Little Rock Arkansas
Not listed Anaheim California
Not listed Rancho Mirage California
Not listed Upland California
Not listed Westlake Village California
Not listed DeLand Florida
Not listed Jupiter Florida
Not listed Kissimee Florida
Not listed Largo Florida
Not listed Longwood Florida
Not listed Palm Harbor Florida
Not listed Sarasota Florida
Not listed Tampa Florida
Not listed Atlanta Georgia
Not listed Paducah Kentucky
Not listed Covington Louisiana
Not listed Towson Maryland
Not listed Brockton Massachusetts
Not listed Haverhill Massachusetts
Not listed Peabody Massachusetts
Not listed Worcester Massachusetts
Not listed Bingham Farms Michigan
Not listed Missoula Montana
Not listed Reno Nevada
Not listed Haddon Heights New Jersey
Not listed Voorhees Township New Jersey
Not listed Albuquerque New Mexico
Not listed New York New York
Not listed Plainview New York
Not listed Rochester New York
Not listed Hickory North Carolina
Not listed High Point North Carolina
Not listed Winston-Salem North Carolina
Not listed Fargo North Dakota
Not listed Cincinnati Ohio
Not listed Dayton Ohio
Not listed Mayfield Village Ohio
Not listed Oklahoma City Oklahoma
Not listed Eugene Oregon
Not listed Duncansville Pennsylvania
Not listed Pittsburgh Pennsylvania
Not listed West Reading Pennsylvania
Not listed Cumberland Rhode Island
Not listed Warwick Rhode Island
Not listed Dallas Texas
Not listed Houston Texas
Not listed San Antonio Texas
Not listed Bountiful Utah
Not listed Sandy City Utah
Not listed Roanoke Virginia
Not listed Virginia Beach Virginia
Not listed Tacoma Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00521989, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2014 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00521989 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →